Revenue
$19.11B
Fiscal year ended 2026-03-31Operating income
Unavailable
Fiscal year ended 2026-03-31Free cash flow
$895.00M
Fiscal year ended 2026-03-31HCA Healthcare, Inc. (HCA) reported revenue of $19.11B and net income of $1.62B for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from HCA Healthcare, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-General Medical & Surgical Hospitals, NEC.
Income
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19.11B | $19.51B | $19.16B | $18.60B | $18.32B | $18.28B | $17.49B | $17.49B | $17.34B | $17.30B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Net income | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 226.65M | Unavailable | shares 236.18M | shares 241.91M | shares 249.44M | Unavailable | shares 259.92M | shares 264.07M | shares 268.02M | Unavailable |
| Pretax income | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B | $2.24B | $2.25B | $2.34B |
| Income tax expense | $430.00M | $509.00M | $515.00M | $524.00M | $502.00M | $447.00M | $424.00M | $550.00M | $445.00M | $484.00M |
| Diluted EPS | $7.15 | Unavailable | $6.96 | $6.83 | $6.45 | Unavailable | $4.88 | $5.53 | $5.93 | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $133.00M | $153.00M | $139.00M | $130.00M | $126.00M | $120.00M | $111.00M | $100.00M | $90.00M | $100.00M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $940.00M | $1.04B | $997.00M | $939.00M | $1.06B | $1.93B | $2.89B | $831.00M | $1.28B | $935.00M |
| Total assets | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B |
| Current assets | $16.05B | $15.78B | $15.28B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B | $15.28B | $14.93B |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B | $14.90B | $14.30B | $13.14B | $12.66B |
| Total equity incl. NCI | -$2.98B | -$2.77B | -$2.16B | -$1.24B | -$438.00M | $555.00M | $786.00M | $1.34B | $1.27B | $1.06B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B | $1.90B | $2.02B |
| Accounts receivable | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B | $9.92B | $10.24B | $10.04B | $9.96B |
| Goodwill | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt | $39.49B | $41.60B | $38.40B | $39.38B | $41.06B | $38.33B | $38.28B | $36.31B | $37.16B | $37.17B |
| Accounts payable | $4.81B | $4.66B | $4.55B | $4.25B | $4.49B | $4.28B | $4.24B | $4.03B | $4.74B | $4.23B |
Cash flow
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B |
| Capital expenditures | $1.12B | $1.49B | $1.29B | $1.18B | $991.00M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B |
| Investing cash flow | -$1.28B | -$1.32B | -$1.39B | -$1.25B | -$1.03B | -$1.35B | -$1.35B | -$1.33B | -$903.00M | -$1.60B |
| Financing cash flow | -$830.00M | -$999.00M | -$2.97B | -$3.09B | -$1.50B | -$2.16B | -$110.00M | -$1.09B | -$1.22B | -$1.04B |
| Net change in cash | -$100.00M | $43.00M | $58.00M | -$121.00M | -$873.00M | -$955.00M | $2.06B | -$453.00M | $349.00M | $44.00M |
| Stock-based compensation | $86.00M | $100.00M | $104.00M | $99.00M | $98.00M | $85.00M | $76.00M | $112.00M | $87.00M | $57.00M |
| Common dividends paid | $183.00M | $162.00M | $166.00M | $171.00M | $180.00M | $165.00M | $169.00M | $171.00M | $185.00M | $160.00M |
| Common share repurchases | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B | $1.80B | $1.37B | $1.18B | $910.00M |
| Depreciation & amortization | $930.00M | $911.00M | $889.00M | $863.00M | $860.00M | $856.00M | $842.00M | $819.00M | $795.00M | $789.00M |
Derived
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $895.00M | $870.00M | $3.13B | $3.03B | $660.00M | $1.27B | $2.32B | $690.00M | $1.35B | $1.52B |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| FCF margin | 4.7% | 4.5% | 16.3% | 16.3% | 3.6% | 7.0% | 13.3% | 3.9% | 7.8% | 8.8% |
| SBC / revenue | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.5% | 0.4% | 0.6% | 0.5% | 0.3% |
| Current ratio | 0.83x | 0.97x | 0.85x | 0.98x | 1.19x | 1.08x | 1.12x | 1.06x | 1.16x | 1.18x |
| Revenue YoY growth | 4.3% | 6.7% | 9.6% | 6.4% | 5.7% | 5.7% | 7.9% | 10.3% | 11.2% | 11.7% |
| Net margin | 8.5% | 9.6% | 8.6% | 8.9% | 8.8% | 7.9% | 7.3% | 8.4% | 9.2% | 9.3% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 5.9% | 7.6% | 6.7% | 6.3% | 5.4% | 7.0% | 6.8% | 7.3% | 6.4% | 6.7% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 18.8% | 19.0% | 21.3% | 21.7% | 21.6% | 21.0% | 22.2% | 24.6% | 19.8% | 20.6% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HCA in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-04-29View SEC filing
10-K · Filed 2026-02-10View SEC filing
10-Q · Filed 2025-10-30View SEC filing
10-Q · Filed 2025-08-04View SEC filing
10-Q · Filed 2025-05-01View SEC filing
10-K · Filed 2025-02-14View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.